These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26255071)

  • 1. Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.
    Sandberg DI; Rytting M; Zaky W; Kerr M; Ketonen L; Kundu U; Moore BD; Yang G; Hou P; Sitton C; Cooper LJ; Gopalakrishnan V; Lee DA; Thall PF; Khatua S
    J Neurooncol; 2015 Oct; 125(1):133-41. PubMed ID: 26255071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reply to: methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial.
    Cohen IJ
    J Neurooncol; 2016 Apr; 127(2):405. PubMed ID: 26732080
    [No Abstract]   [Full Text] [Related]  

  • 3. Infusion of 5-Azacytidine (5-AZA) into the fourth ventricle or resection cavity in children with recurrent posterior Fossa Ependymoma: a pilot clinical trial.
    Sandberg DI; Yu B; Patel R; Hagan J; Miesner E; Sabin J; Smith S; Fletcher S; Shah MN; Sirianni RW; Taylor MD
    J Neurooncol; 2019 Jan; 141(2):449-457. PubMed ID: 30460634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Administration of Chemotherapy and Other Agents into the Fourth Ventricle to Treat Recurrent Malignant Brain Tumors in Children.
    Sandberg DI; Yu B
    Adv Tech Stand Neurosurg; 2024; 53():119-137. PubMed ID: 39287806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy administration directly into the fourth ventricle in a nonhuman primate model.
    Sandberg DI; Peet MM; Johnson MD; Cole P; Koru-Sengul T; Luqman AW
    J Neurosurg Pediatr; 2012 May; 9(5):530-41. PubMed ID: 22546032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase-contrast cerebrospinal fluid flow magnetic resonance imaging in qualitative evaluation of patency of CSF flow pathways prior to infusion of chemotherapeutic and other agents into the fourth ventricle.
    Patel RP; Sitton CW; Ketonen LM; Hou P; Johnson JM; Romo S; Fletcher S; Shah MN; Kerr M; Zaky W; Rytting ME; Khatua S; Sandberg DI
    Childs Nerv Syst; 2018 Mar; 34(3):481-486. PubMed ID: 29170836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model.
    Sandberg DI; Solano J; Petito CK; Mian A; Mou C; Koru-Sengul T; Gonzalez-Brito M; Padgett KR; Luqman A; Buitrago JC; Alam F; Wilkerson JR; Crandall KM; Kuluz JW
    J Neurooncol; 2010 Dec; 100(3):397-406. PubMed ID: 20440538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular access device placement in the fourth ventricle to treat malignant fourth ventricle brain tumors: technical note.
    Sandberg DI; Kerr ML
    Childs Nerv Syst; 2016 Apr; 32(4):703-7. PubMed ID: 26597683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose MTX110 (soluble panobinostat) safely administered into the fourth ventricle in a nonhuman primate model.
    Sandberg DI; Kharas N; Yu B; Janssen CF; Trimble A; Ballester LY; Patel R; Mohammad AS; Elmquist WF; Sirianni RW
    J Neurosurg Pediatr; 2020 Aug; 26(2):127-135. PubMed ID: 32357333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model.
    Sandberg DI; Crandall KM; Koru-Sengul T; Padgett KR; Landrum J; Babino D; Petito CK; Solano J; Gonzalez-Brito M; Kuluz JW
    J Neurooncol; 2010 Mar; 97(1):25-32. PubMed ID: 19688296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination chemotherapy with MOPP and intrathecal methotrexate in children with brain tumors].
    Sato J; Ninomiya T; Saijo T; Akita H; Miki Y; Hirose M; Hashimoto T; Miyao M; Matsumoto K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3266-70. PubMed ID: 3777962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study.
    Fouladi M; Blaney SM; Poussaint TY; Freeman BB; McLendon R; Fuller C; Adesina AM; Hancock ML; Danks MK; Stewart C; Boyett JM; Gajjar A
    Cancer; 2006 Nov; 107(9):2291-7. PubMed ID: 17019740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
    Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
    J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalopathy following the administration of methotrexate into the cerebrospinal fluid in the treatment of primary brain tumors.
    Norrell H; Wilson CB; Slagel DE; Clark DB
    Cancer; 1974 Apr; 33(4):923-32. PubMed ID: 4819222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and micro-neurosurgery for the fourth cerebral ventricle tumors].
    Hu WW; Zheng XJ; Shen G; Liu WG; Shen H; Fu WM; Zhou JY
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):144-6. PubMed ID: 17645855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma.
    Khatua S; Cooper LJN; Sandberg DI; Ketonen L; Johnson JM; Rytting ME; Liu DD; Meador H; Trikha P; Nakkula RJ; Behbehani GK; Ragoonanan D; Gupta S; Kotrotsou A; Idris T; Shpall EJ; Rezvani K; Colen R; Zaky W; Lee DA; Gopalakrishnan V
    Neuro Oncol; 2020 Aug; 22(8):1214-1225. PubMed ID: 32152626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy administration directly into the fourth ventricle in a new piglet model. Laboratory Investigation.
    Sandberg DI; Crandall KM; Petito CK; Padgett KR; Landrum J; Babino D; He D; Solano J; Gonzalez-Brito M; Kuluz JW
    J Neurosurg Pediatr; 2008 May; 1(5):373-80. PubMed ID: 18447671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric voxelwise apparent diffusion coefficient histogram analysis for differentiation of the fourth ventricular tumors.
    Payabvash S; Tihan T; Cha S
    Neuroradiol J; 2018 Dec; 31(6):554-564. PubMed ID: 30230411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for medulloblastoma and ependymoma using iv vincristine, intrathecal methotrexate, and intrathecal hydrocortisone: a Southwest Oncology Group Study.
    van Eys J; Chen T; Moore T; Cheek W; Sexauer C; Starling K
    Cancer Treat Rep; 1981; 65(7-8):681-4. PubMed ID: 7248985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.